Oncotarget: Life Without Disease

Our existence, as the most developed species on Earth, relies on intelligence and determination to understand how our body functions and what we can do to help with its constant battle for survival. Diseases that were once deemed rare are becoming extremely common. With no cures, many patients’ lives are endangered. Being born in a generation full of technological advancements, I believe that, with my passion for biology and inquisitiveness for the world of biomedical science, now is the time to engage in this global challenge to develop easier and better ways to live our lives.

“Excluding non-melanoma skin cancer, the global cancer incidence has increased from 12.7 million in 2008 to 14.1 million in 2012, and the expected trend is an increase in new cases to close to 25 million over the next two decades” (De Mello, Tavares, Mountzios). Now, in 2016, the trend is continuing to climb. With that number of people being diagnosed with cancer, it’s just common sense that we need more and more people to help them fight the cancer. Those who are diagnosed are dependent on oncologists. The need for oncologists is higher than ever and is continuing to increase each year. This paper will explain what oncology is, what several of the different types of oncologists, and the education requirements to become a certified oncologist.

Contemporary scientific progression and discourses allude to the emergence of an increasingly technological future. Implicit within this notion is the premise that emerging technologies can be used to open new frontiers that benefit and promote human advancement. Intuitively, this stipulation can be extrapolated to medicine where present technologies play a critical mantle in upholding the therapeutic and traditional aims of medical doctrine. But beyond conventional medical applications of technologies, many have begun to recognize their underlying potential for not only treatment, but enhancement of our present biological state.

Luke Timmerman is a trained journalist who has worked for quite some time in biotech journalism. He gives a brief history of his life and work history over the years, and his journey to becoming a biotech journalist. He went through some challenges especially writing for different contexts such as business audiences and insiders. He has strived to be a journalist known for the quality of his work rather than the number of clicks. There are tremendous possibilities in the biotech field, writing in this context is promising, Timmerman recounts when he started writing and how he felt privileged working especially with work on cancer. Public engagement is important but not always necessary. Money has a significant role in biotech, especially financing

Nusrat Epsi, MBA is a PhD student working at the Rutgers University, School of Healthcare Professional with Dr. Antonina Mitrafanova. Prior to beginning the PhD program, Nusrat worked in the Pharmaceutical Industry. She consulted on a variety of projects which involved both qualitative and quantitative analysis to achieve strategic realignments within large pharmaceutical systems. From this work she developed an interest in drug discovery and drug structure. She is currently working on designing possible targeted cancer therapy to interfere with specific AR genes for tumor growth and progression. She also had a primary interest in the invasion of bladder cancer. She is also interested studying other Hormonal carcinogenesis. For her doctoral

Traditional chemotherapy typically lasts one to three years; however, virotherapy has proven to eliminate tumors in less than two weeks. While many chemotherapy treatments can cost more than $5,000 a month, adding drugs to this cost, according to the Food and Drug Administration, treatment for a year of priced above $100,000. Contrasting to chemotherapy, oncolytic virotherapy, since it is one single treatment, would cost a patient only $20,000. The modified T-cells are still able to reproduce even after the viruses has killed all the cancer cells. By doing so, it provides the patient’s body’s own immune system the lasting ability to fight cancer. In 2015, more than 86% of patients diagnosed with advanced cancer can hope for six to ten months, even those with better statistics than this heart-breaking one must undergo months/years of intensive, as well as expensive, toxic chemotherapy (Grady). With this new method of treatment, these statistics are expected to significantly change — longer lives as well as significantly less painful

It was the beginning of another week and I was really excited. My company, Fibre Health had just become a Fortune 500 company. I was 18 years old when I first thought of the idea of using fibre to fight cancer. The fibre washes out the cancer cells into your feces. Fibre Health had grown even further in the past 8 years when I had the

I have just completed my PhD research in Molecular Oncology at the FIRC Institute of Molecular Oncology, Milan, Italy. During this period, I have worked successfully on several projects and have supervised team members. As the lead author of two peer-reviewed papers and several other works (posters, theses, abstracts, research reports), I was responsible for defining the structure of the articles, for writing the manuscripts, and even for creating illustrations.

Cancer has become an epidemic across America. About 13 million Americans have cancer and a little over 1 million are diagnosed every year. For years Oncologist have been looking for treatments to cure this horrible disease(American Cancer Society, 2013). Chemistry has such a major impact on the research of cancer. The chemistry within Oncology & Cancer Research has greatly increased our knowledge and capabilities for developing new treatments or actually finding a significant cure (American Cancer Society,2013). This paper is explaining how chemistry is used to seek out cancer cells, treat, and also inform how the different chemicals are affecting our body.

Oncotarget publishes under a Creative Commons Attribution License, where the researcher's contribution to cancer research is recognized by redistribution, reuse and frequent frequent citations of his or her paper worldwide. Free, unrestricted access to papers published on Oncotarget allows for global dissemination of exceptional discoveries, providing valuable cancer research information to any individual interested in oncology. Authors also receive additional exposure through Oncotarget's Facebook page, which includes the latest featured cover article and interviews with authors. Links to the latest issues of the journal are also on Oncotarget's LinkedIn page.

Cancer is the cause of death in one out of four people in the United States.{Cronin, 2014 #124;Ward, 2014 #128} The mortality rate has been almost constant in spite of all new discoveries to cure cancer in the past few decades{Cronin, 2014 #124}. This shows that several contributing factors play major roles. The practice of clinical oncology focuses on the diversity on cancer cells.

Cancer is a topic that has been discussed thoroughly due to the burden that it has on the affected. It has also been researched early on. According to Dr. George Demetri, director at the Dana-Farber Cancer Institute, cancer violently spreads and attacks organs in the body, which leads to health complications (PBS 1). The world’s understanding of cancer has evolved, but there are still questions that no one has the answer to. Aktipis notes that cancer cells are able to spread to other organs and withstand treatment (Aktipis 2). In other words,the effectiveness of treatment can not be guaranteed due to the the fast pace of spreading. The study of oncology, another term for cancer, started in the eighteenth century and has grown

Therefore, we can’t simply wake up one day, suddenly knowing the ins and outs of this disease’s mechanisms and processes. Due to the fact that developing treatments and countermeasures for cancer requires an understanding, research is very obviously an integral part to solving the riddle. While we do currently possess a limited knowledge of cancer, our knowledge is just that, limited. How can we ever hope to develop more effective treatments when the information we’re basing our ideas on is outdated and static? Simply put, we need to update our understanding of this disease, and research is our

Recent Research in Oncology and Treatment is a medical journal that addresses to educate the health professionals and specialists about the standard, quality and value of care and development in science, and health services research to be provided to patients suffering from cancer.

“A very warm welcome and thank you for joining us,” she began cheerfully. “This is Stacy Smith, bringing you World News Evening Edition. Our top story now is the newly discovered method of preventing cancer. A world renowned scientist, Dr. Rod Stinguard of the Greysville Quadrant Hospital in Keswick, has announced the launch of the Stinguard viral vector in Tanga, Tanzania in three months.”